Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study (Q85075980)
Jump to navigation
Jump to search
scientific article published on 01 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study |
scientific article published on 01 July 2011 |
Statements
Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study (English)
Sanda Jelisavac-Cosic
Maja Sirotkovic-Skerlev
Ana Kulic
Jasminka Jakic-Razumovic
Zdenko Kovac